GeneDx Holdings (WGS) Reports Q4 results; offers guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- US stock futures rise as investors assess Democrats' midterm sweep
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mailGet Alerts WGS Hot Sheet
Join SI Premium – FREE
GeneDx Holdings (NASDAQ: WGS) reported Q4 Revenue for the quarter at $95.3 million versus the consensus estimate of $61.7 million.
GUIDANCE:
GeneDx Holdings sees FY2025 revenue of $350-360 million, versus the consensus of $338.8 million.
For earnings history and earnings-related data on GeneDx Holdings (WGS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Camtek Ltd (CAMT) Reports In-Line Q3 EPS, Beats on Revenue; Offers FY26 Revenue Guidance
- Zimmer Biomet Holdings (ZBH) Tops Q3 EPS by 2c; updates guidance
- Timken (TKR) Tops Q3 EPS by 17c, Offers FY26 EPS Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
